Bal Pharma Ltd vs Caplin Point Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Bal Pharma Ltd is ₹ 87 as of 10 Jun 14:29 . The P/E Ratio of Bal Pharma Ltd changed from 16.8 on March 2021 to 18.4 on March 2025 . This represents a CAGR of 1.84% over 5 yearsThe P/E Ratio of Caplin Point Laboratories Ltd changed from 12.6 on March 2021 to 28.4 on March 2025 . This represents a CAGR of 17.65% over 5 years The Market Cap of Bal Pharma Ltd changed from ₹ 79.67 crore on March 2021 to ₹ 132.4 crore on March 2025 . This represents a CAGR of 10.69% over 5 yearsThe Market Cap of Caplin Point Laboratories Ltd changed from ₹ 3057 crore on March 2021 to ₹ 15222 crore on March 2025 . This represents a CAGR of 37.86% over 5 years The revenue of Bal Pharma Ltd for the Mar '26 is ₹ 83.84 crore as compare to the Dec '25 revenue of ₹ 88.02 crore. This represent the decline of -4.75% The revenue of Caplin Point Laboratories Ltd for the Mar '26 is ₹ 628.52 crore as compare to the Dec '25 revenue of ₹ 576.45 crore. This represent the growth of 9.03% The ebitda of Bal Pharma Ltd for the Mar '26 is ₹ 10.33 crore as compare to the Dec '25 ebitda of ₹ 9.87 crore. This represent the growth of 4.66% The ebitda of Caplin Point Laboratories Ltd for the Mar '26 is ₹ 232.6 crore as compare to the Dec '25 ebitda of ₹ 223.35 crore. This represent the growth of 4.14% The net profit of Bal Pharma Ltd changed from ₹ 0.26 crore to ₹ 3.6 crore over 8 quarters. This represents a CAGR of 272.10% The net profit of Caplin Point Laboratories Ltd changed from ₹ 124.92 crore to ₹ 172.88 crore over 8 quarters. This represents a CAGR of 17.64% The Dividend Payout of Bal Pharma Ltd changed from 16.29 % on March 2021 to 24.49 % on March 2025 . This represents a CAGR of 8.50% over 5 yearsThe Dividend Payout of Caplin Point Laboratories Ltd changed from 14.53 % on March 2021 to 13.43 % on March 2025 . This represents a CAGR of -1.56% over 5 years .

About Bal Pharma Ltd

Bal Pharma Limited (BPL), a member of the Mcro Laboratories Group, was incorporated as a private limited company in May 1987.
In March 1990, BPL took over a pharmaceutical products manufacturing unit located in Bangalore through the Karnataka State Finance Corporation for a consideration of Rs 25.18 lac following which, BPL commenced manufacturing formulations. BPL manufactures and markets pharmaceutical formulations -- paracetamol, aluminium hydroxide, povidone iodine, alprazolam, gliclazide, griseofulvin, lactobacillus, rifampicin, piroxicam amoxycillin, etc.
The company promotes its products through the common sales force of the group but proposes to induct its own soon.
It came out with a public issue in Feb.'95 for manufacture of bulk drugs and expansion of pharmaceutical formulations.

About Caplin Point Laboratories Ltd

Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
The Company is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

FAQs for the comparison of Bal Pharma Ltd and Caplin Point Laboratories Ltd

Which company has a larger market capitalization, Bal Pharma Ltd or Caplin Point Laboratories Ltd?

Market cap of Bal Pharma Ltd is 138 Cr while Market cap of Caplin Point Laboratories Ltd is 17,160 Cr

What are the key factors driving the stock performance of Bal Pharma Ltd and Caplin Point Laboratories Ltd?

The stock performance of Bal Pharma Ltd and Caplin Point Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bal Pharma Ltd and Caplin Point Laboratories Ltd?

As of June 10, 2026, the Bal Pharma Ltd stock price is INR ₹87.08. On the other hand, Caplin Point Laboratories Ltd stock price is INR ₹2257.6.

How do dividend payouts of Bal Pharma Ltd and Caplin Point Laboratories Ltd compare?

To compare the dividend payouts of Bal Pharma Ltd and Caplin Point Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.